- Half of South Asians have a genetic mutation that renders clopidogrel ineffective
Evidence suggests that a commonly prescribed blood-thinner, clopidogrel, may not be effective for individuals of South Asian descent.
Over half of individuals with Bangladeshi and Pakistani ancestry possess a genetic mutation that renders the drug ineffective.
Clopidogrel, also known as Plavix, is widely used by millions of Britons to prevent heart attacks and strokes. It acts by inhibiting blood cell adhesion, reducing the risk of clot formation.
Previous studies have shown that a significant proportion of the population does not respond to the medication due to a genetic mutation in the CYP2C19 gene, which is responsible for producing an enzyme that activates the drug in the liver.
Research involving European populations estimated that around a third of individuals are affected by this genetic mutation.
More than half of those with Bangladeshi and Pakistani ancestry have a genetic mutation that stops the drug, clopidogrel, from working properly
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
